These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37953977)

  • 1. Patient and Physician Preferences for Acute Myeloid Leukemia Maintenance Treatments Following Hematopoietic Stem Cell Transplantation.
    Saini L; Griffin JD; Pandya BJ; Shah MV; Zhou M; Yang H; Song Y; Marshall DA
    Patient Prefer Adherence; 2023; 17():2805-2819. PubMed ID: 37953977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
    Mühlbacher AC; Nübling M
    Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment.
    Morse AM; Krahn L; Flygare J; Kushida C; Thorpy MJ; Athavale A; Gudeman J
    Adv Ther; 2023 Jul; 40(7):3199-3216. PubMed ID: 37243863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
    Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
    Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrete Choice Experiment to Understand Japanese Patients' and Physicians' Preferences for Preventive Treatments for Migraine.
    Seo J; Tervonen T; Ueda K; Zhang D; Danno D; Tockhorn-Heidenreich A
    Neurol Ther; 2023 Apr; 12(2):651-668. PubMed ID: 36848008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.
    Seo J; Smith BD; Estey E; Voyard E; O' Donoghue B; Bridges JFP
    Curr Med Res Opin; 2018 Dec; 34(12):2031-2039. PubMed ID: 29565196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy.
    Cornelisse S; Vos MS; Groenewoud H; Mastenbroek S; Ramos L; Braat DDM; Stalmeier PFM; Fleischer K
    Hum Reprod Open; 2022; 2022(3):hoac030. PubMed ID: 35928049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
    Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
    Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
    BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
    Deng DX; Wen JJ; Cheng YF; Zhang XH; Xu LP; Wang Y; Yan CH; Chen YH; Chen H; Han W; Wang FR; Wang JZ; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
    BMC Cancer; 2021 Mar; 21(1):292. PubMed ID: 33740924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and physician preferences for ulcerative colitis treatments in the United States.
    Boeri M; Myers K; Ervin C; Marren A; DiBonaventura M; Cappelleri JC; Hauber B; Rubin DT
    Clin Exp Gastroenterol; 2019; 12():263-278. PubMed ID: 31354328
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
    de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
    Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment.
    Mühlbacher AC; Stoll M; Mahlich J; Nübling M
    Health Econ Rev; 2013 Dec; 3(1):30. PubMed ID: 24351422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer.
    Stone RL; Cambron-Mellott MJ; Beusterien K; Maculaitis MC; Ritz S; Mulvihill E; Monberg M; Szamreta EA; Amin S; McLaurin K
    Future Oncol; 2022 Feb; 18(4):491-503. PubMed ID: 34875854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.
    Xuan L; Wang Y; Yang K; Shao R; Huang F; Fan Z; Chi P; Xu Y; Xu N; Deng L; Li X; Liang X; Luo X; Shi P; Liu H; Wang Z; Jiang L; Lin R; Chen Y; Tu S; Zhang Y; Sun J; Huang X; Liu Q
    Lancet Haematol; 2023 Aug; 10(8):e600-e611. PubMed ID: 37414062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.
    Willems D; Hinzpeter EL; Van der Zee HH; Sayed CJ; Ingram JR; Beaudart C; Evers SMAA; Hiligsmann M
    Patient; 2023 Mar; 16(2):153-164. PubMed ID: 36630078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.